Comprehensive Screening of Cell Surface Markers Expressed by Adult-Derived Human Liver Stem/Progenitor Cells Harvested at Passage 5: Potential Implications for Engraftment

Table 2

Expression of MSC markers of ADHLSCs and comparison with BM-MSC and ASC.

Markers	ADHLSC	BM-MSC [14, 15]	ASC [15]
CD73	98.3% (95.0–99.7)	≥95% (guideline)	≥95%
CD90	91.5% (86.9–95.0)	≥95% (guideline)	≥95%
CD105	96.7% (93.8–99.6)	≥95% (guideline)	≥95%
CD11b	0.7% (0.0–2.0)	≤2% (guideline)	≤2%
CD14	2.0% (0.0–3.26)	≤2% (guideline)	≤2%
CD19	0.5% (0.0–2.0)	≤2% (guideline)	≤2%
CD45	1.1% (0.0–2.8)	≤2% (guideline)	≤2%
HLA-DR	0.8%  ± 0.5	≤2% (guideline)	≤2%
CD34	1.3% (0.1–2.6)	0.1% (0.0−0.1)	9.0% (5.1–30.1)
CD36	3.5% (0.0–12.0)	0.1% (0.0−0.2)	11.5% (4.8–13.4)
CD91	0.7% (0.0−1.7)	N.D.	47.6% (12.7–87.4)
CD140b	93.8% (99.4–78.6)	54.3% (45.9–87.5)	79.9% (49.2–87.5)
CD141	7.2% (4.2–12.8)	N.D.	≥95%
CD201	53.3% (0.17–81.1)	2.0% (1.8–4.8)	13.6% (9.5–25.6)